Unified Namespace (UNS) has emerged as a cornerstone concept for the Life Sciences industry given its potential to be the "single source of truth" for real-time data and events. Yet, evolving definitions have led to a gap between vision and reality, leading organizations to shape an implementation roadmap driven by their specific data management priorities.

In this session, we will:

1. Provide a "state of the market" analysis of UNS adoption within Life Sciences, drawn directly from recent client engagements and digital transformation initiatives. 

2. Share and compare examples of UNS projects (in Life Sciences and other industries) to understand adoption trends and priorities.

3. Explain how the AVEVA portfolio supports UNS concepts from a data lifecycle management perspective.